Power-Pak C.E. is pleased to present a complimentary live CE webinar

Presenter

Christopher Fausel, PharmD, MHA, BCOP (Chair)

Clinical Manager, Oncology Pharmacy
Indiana University Health
Indianapolis, IN

Larry W. Buie, PharmD, BCOP, FASHP

Clinical Pharmacy Manager and PGY2 Oncology Residency Program Director
Memorial Sloan Kettering Cancer Center
New York, NY

R. Donald Harvey III, PharmD, BCOP, FCCP, FHOPA

Professor, Department of Hematology and Medical Oncology and Department of Pharmacology and Chemical Biology
Emory University School of Medicine
Director, Phase l Clinical Trials Section
Atlanta, GA

Laura K. Whited, PharmD, BCOP

Clinical Pharmacy Specialist-Stem Cell Transplantation & Cellular Therapy
University of Texas MD Anderson Cancer Center
Houston, TX
Dates/Times:
Thursday, October 3, 2019
6:00 – 7:30 PM Eastern Time (US)
Tuesday, October 8, 2019
2:30 – 4:00 PM Eastern Time (US)
Wednesday, October 23, 2019
11:00 AM – 12:30 PM Eastern Time (US)

Goal Statement  The goal of this educational activity is to inform and educate oncology, managed care and specialty pharmacists on differences in pharmacology, efficacy, and safety of BTK inhibitors and roles that pharmacists can play to drive appropriate access to and use of BTK inhibitors to optimize outcomes for patients with mature B-cell neoplasms.

Educational Objectives  Upon completion of this program, participants should be better able to:

1.

Compare and contrast the BTK inhibitors, including their pharmacological differences

2.

Discuss key published clinical trials, ongoing clinical trials, and guideline recommendations for BTK inhibitors in MCL and CLL

3.

Design a treatment plan involving an appropriate BTK inhibitor and corresponding safety considerations

4.

Formulate effective strategies for ensuring the proper selection and use of BTK inhibitors in the care of individual patients and patient populations

Credits: 1.5 hour (0.15 ceu)

Duration: 90 minutes

Location: From the convenience of your home or business; accessible via both PC and MAC

Fee: There is no fee for this educational activity

Target Audience: Oncology, managed care and specialty pharmacists

Type of Activity: Application

Agenda

Introduction (5 minutes)

Presentation (75 minutes)

Conclusions & Question & Answer Session (10 minutes)

How to Earn Credit  Participants must attend and participate in the entire live educational activity and complete the posttest and evaluation form directly after the event with a maximum of within 60 days of participating in the activity.

Required Computer Hardware/Software  Please ensure the computer system you plan to use meets the following minimum requirements:

•

Operating System: Windows 98 or higher & Macintosh 2.2 or higher

•

Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher

•

Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible

•

Peripherals: Computer speakers or headphones

•

Monitor Screen Resolution: 320 x 480 or higher

•

Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

Accreditation Statements

Pharmacy: Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-0000-19-091-L01-P

This educational activity is sponsored by Postgraduate Healthcare Education, LLC (PHE) and supported by an educational grant from AstraZeneca Pharmaceuticals LP.